Enhancement of radiation and hyperthermia effects for oral cancer by intracellular hydrogen peroxide generator

细胞内过氧化氢发生器增强口腔癌的放射和热疗效果

基本信息

项目摘要

The enhancement of heat-induced apoptosis by 6-formylpterin, an intracellular generator of hydrogen peroxide (H_2O_2), was examined in human myelomonocytic lymphoma U937 cells. The cells were treated with either 6-formylpterin alone at a nontoxic concentration of 300 μM (37℃), heat shock (44℃/20min) alone, or a combination of the two, then incubated at 37℃ for 6 h. Assessments of apoptosis, mitochondrial membrane potential, and caspase-3 activation were performed by flow cytometry. Moreover, caspase-8 activation, and changes in the intracellular Ca^<2+> concentration ([Ca^<2+>]i) were examined. Bax,Bcl-2,Bcl-XL,Bid, cytochrome c, and PKCδ were detected by Western blotting. The induction of heat-induced apoptosis evaluated by morphological observation and DNA fragmentation were promoted by the addition of 6-formylpterin. Mitochondrial membrane potential was decreased and the activation of caspase-3 and -8 was enhanced in the cells treated with the combination. A decreased-expression of … More Bid was noted, although no significant changes in Bax,Bcl-2, and Bcl-XL expression were observed after the combined treatment. Furthermore, both the release of cytochrome c from mitochondria to cytosol and the translocation of PKCδ from cytosol to mitochondria, which were induced by heat shock, were enhanced by the addition of 6-formylpterin. The number of cells with a higher [Ca^<2+>]i was also increased by the addition of 6-formylpterin. These findings suggest that the increase in [Ca^<2+>]i, the activation of the mitochondria-caspase dependent pathway, and the translocation of PKCδ to mitochondria play principal roles in the enhancement of heat-induced apoptosis by 6- formylpterin. These results were confirmed in the cells exposed to X-ray at a dose of 10Gy, too. When cells were exposed to hyperthermia alone (44℃ for 10 min, 15% apoptosis level), 39 up-regulated genes, such as BAG3,DNAJA1,DNAJB1,HSPA1B,HSPA6,HSPH1,SEPW1, and HO-1,and 3 down-regulated gene, such as CCL2,were identified. In combining heat and 6- formylpterin, two up-regulated genes (LOC219962 and NEUROD4) were identified. The expression levels of these genes were confirmed by real-time quantitative polymerase chain reaction. Less
在人脊髓细胞淋巴瘤U937细胞中检查了6-甲基甲基蛋白的热诱导凋亡(H_2O_2)的细胞内发生器(H_2O_2)的增强。单独用单独的6-甲基蛋白的细胞以300μM(37℃),热休克(44℃/20分钟)或两者的组合处理,然后在37℃孵育6小时。通过流式细胞仪进行凋亡,线粒体膜电位和caspase-3激活的评估。此外,检查了caspase-8激活以及细胞内Ca^<2+>浓度的变化([Ca^<2+>] i)。通过蛋白质印迹检测到BAX,BCL-2,BCL-XL,BID,BID,细胞色素C和PKCδ。通过添加6-甲基甲基蛋白来促进通过形态学观察和DNA碎片评估的热诱导的凋亡的诱导。线粒体膜电位得到了改善,并在结合处理的细胞中增强了caspase -3和-8的激活。尽管在联合治疗后观察到BAX,BCL-2和BCL-XL表达没有明显变化,但提出了更多的出价表达。此外,通过添加6型甲状腺蛋白,可以增强细胞色素C从线粒体到细胞质的释放,以及通过热休克诱导的PKCδ从细胞胞醇转移到线粒体。通过添加6型甲酰基蛋白,增加了[Ca^<2+>]较高的细胞数量。这些发现表明,[Ca^<2+>] I的增加,线粒体 - caspase依赖途径的激活以及PKCδ向线粒体的易位在增强热诱导的凋亡在6-甲基蛋白中的结果中起主要作用。这些结果在暴露于X射线的细胞中也得到了证实,也以10GY的剂量剂量确认。当细胞单独暴露于高温(44℃10分钟,15%凋亡水平)时,39个上调的基因,例如BAG3,DNAJA1,DNAJB1,DNAJB1,HSPA1B,HSPA1B,HSPA6,HSPH1,HSPH1,SEPW1和HO-1和HO-1和HO-1,以及3个下调的基因,例如CCL2。在结合热和6-甲基甲蛋白时,鉴定了两个上调的基因(LOC219962和NeuroD4)。这些基因的表达水平通过实时定量聚合酶链反应证实。较少的

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Enhancement of radiation-induced apoptosis by 6-formylpterin
  • DOI:
    10.1080/1071576042000191754
  • 发表时间:
    2004-04-01
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Cui, ZG;Kondo, T;Makino, K
  • 通讯作者:
    Makino, K
Enhancement of hyperthermia-induced apoptosis by modification of intracellular oxidative stress.
通过改变细胞内氧化应激来增强热疗诱导的细胞凋亡。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WADA Shigehito其他文献

WADA Shigehito的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WADA Shigehito', 18)}}的其他基金

Oral cancer therapy by differential temperature control using nano-particle
使用纳米颗粒进行温差控制的口腔癌治疗
  • 批准号:
    20592355
  • 财政年份:
    2008
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Enhancement of apoptosis in oral cancer cells by intracellular reactive oxygen amplication
细胞内活性氧扩增增强口腔癌细胞凋亡
  • 批准号:
    18592214
  • 财政年份:
    2006
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Ac-225标记的工程化细菌外膜囊泡用于肿瘤放射免疫治疗与机制探究
  • 批准号:
    32301169
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肿瘤微环境响应性仿生纳米材料用于三阴性乳腺癌的时空可控预靶向放射性核素治疗
  • 批准号:
    82302246
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
建立基于超声图像引导的前列腺癌智能自适应放射治疗方法
  • 批准号:
    62371243
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
局部晚期非小细胞肺癌患者预后导向的放射治疗计划优化策略的研究
  • 批准号:
    82303947
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ANLN调控甲状腺乳头状癌放射碘治疗抵抗的作用和机制研究
  • 批准号:
    82373366
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Proton radiation therapy combined with immunotherapy for enhancing antitumor immune responses in pancreatic cancer murine models.
质子放射治疗与免疫治疗相结合,增强胰腺癌小鼠模型的抗肿瘤免疫反应。
  • 批准号:
    24K10423
  • 财政年份:
    2024
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
  • 批准号:
    10752046
  • 财政年份:
    2024
  • 资助金额:
    $ 1.6万
  • 项目类别:
Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
  • 批准号:
    10991546
  • 财政年份:
    2024
  • 资助金额:
    $ 1.6万
  • 项目类别:
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
  • 批准号:
    10751872
  • 财政年份:
    2024
  • 资助金额:
    $ 1.6万
  • 项目类别:
Development of internal radiation therapy agents for refractory breast cancer based on phase-shift using focused ultrasound
基于聚焦超声相移的难治性乳腺癌体内放射治疗剂的开发
  • 批准号:
    23H02866
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了